the FDA has stated it lacks sufficient information to know whether the substance would cause harm when administered to humans Evidence snapshot: The evidence base is almost entirely preclinical, decades of animal (largely rat) studies, mostly from one Croatian research group (Sikiric et al., University of Zagreb), with a single small human trial under the brand name "Bepecin" (around 2015) that did not lead to any FDA-approved use
Evidence GHK-Cu is associated with regulation across more than 4,000 genes, including collagen synthesis, antioxidant defense, wound healing, inflammation, and tissue breakdown
Maintaining a Reproducible Storage Log Just as batch-specific COA tracking strengthens reproducibility on the purity side, a simple storage log strengthens it on the handling side
These effects lead to faster recovery and improved structural integrity following injury, making it one of the most researched compounds in tissue regeneration and recovery science